This mutation is deposited by different laboratories at least 5 times at the LOVD. The proband had triple negative breast cancer (the type of cancer most frequently associated with BRCA1 mutations) at 47, was tested at 49 and had a sister who died of breast cancer at 46. This evidence concerns the gene BRCA1 and triple-negative breast carcinoma.